Evidence map›Paper›PMID 34917599›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Banking of AT-MSC and its Influence on Their Application to Clinical Procedures.

Ekaterina Semenova, Mariusz P Grudniak, Katarzyna Bocian, Magdalena Chroscinska-Krawczyk, Marzena Trochonowicz, Igor M Stepaniec, Magdalena Murzyn, Ilona Szablowska-Gadomska, Dariusz Boruczkowski, Tomasz Oldak and 1 more

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ekaterina SemenovaPolish Stem Cell Bank, FamiCord Group, Warsaw, Poland.
Mariusz P GrudniakPolish Stem Cell Bank, FamiCord Group, Warsaw, Poland.
Katarzyna BocianPolish Stem Cell Bank, FamiCord Group, Warsaw, Poland.
Magdalena Chroscinska-KrawczykClinic of Paediatric Neurology, III Faculty of Paediatrics, Medical University of Lublin, Lublin, Poland.
Marzena TrochonowiczPolish Stem Cell Bank, FamiCord Group, Warsaw, Poland.
Igor M StepaniecPolish Stem Cell Bank, FamiCord Group, Warsaw, Poland.
Magdalena MurzynPolish Stem Cell Bank, FamiCord Group, Warsaw, Poland.
Ilona Szablowska-GadomskaLaboratory for Cell Research and Application, Medical University of Warsaw, Warsaw, Poland.
Dariusz BoruczkowskiPolish Stem Cell Bank, FamiCord Group, Warsaw, Poland.
Tomasz OldakPolish Stem Cell Bank, FamiCord Group, Warsaw, Poland.
Eugeniusz K MachajPolish Stem Cell Bank, FamiCord Group, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Processing of MSCs to obtain a therapeutic product consists of two main steps: 1) the

Indexed as

ADSCapplicationbankingcryopreservationcryoprotectant

Identifiers

PMID34917599
PMCPMC8670380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.